GlassScriptPhysician profile
Rachel Limmer
NPI 1760599054
$3,505.64
in general payments reported to CMS, 2019-2025
20 companies · $526 in 2025
The $526 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $740 · 2020: $100 · 2021: $208 · 2022: $132 · 2023: $804 · 2024: $996 · 2025: $526.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,326.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,326.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $556.46 | 2019-2024 | Cabtreo, Arazlo |
| Abbvie INC. | $449.40 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $272.93 | 2024 | |
| Janssen Scientific Affairs, LLC | $249.99 | 2019-2021 | |
| Janssen Biotech, INC. | $249.98 | 2023-2024 | Tremfya |
| Regeneron Healthcare Solutions, INC. | $242.78 | 2023-2025 | Dupixent |
| Lilly USA, LLC | $210.75 | 2019-2024 | |
| Ucb, INC. | $171.17 | 2023-2024 | Bimzelx |
| Organon LLC | $154.16 | 2025 | Vtama |
| Boehringer Ingelheim Pharmaceuticals, INC. | $122.10 | 2023 | Spevigo |
| Kyowa Kirin, INC. | $118.21 | 2024 | Poteligeo |
| Verrica Pharmaceuticals INC. | $113.32 | 2023 | Ycanth |
| Biofrontera INC. | $112.53 | 2019 | |
| Incyte Corporation | $111.81 | 2023-2024 | Opzelura |
| Galderma Laboratories, L.P. | $98.02 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leo Pharma INC. | $97.43 | 2024-2025 | Anzupgo, Adbry |
| Pfizer INC. | $77.88 | 2022 | |
| Celgene Corporation | $51.00 | 2019 | |
| Elekta, INC. | $26.12 | 2025 | Flexitron Hdr |
| Journey Medical Corporation | $19.60 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rachel Limmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.